RLMD
Relmada Therapeutics Inc.
$7.61
$0.00(0.00%)
45
Overall
60
Value
63
Tech
13
Quality
Market Cap
$50.78M
Volume
1.56M
52W Range
$0.24 - $7.51
Target Price
$12.80
Key Metrics Overview
| Market Cap | $50.78M | P/E Ratio | N/A |
| 52W High | $7.51 | 52W Low | $0.24 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 28.2% | 52W Position | 101.4% |
| Overall Score | 45 | Value Score | 60 |
| Quality Score | 13 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-0.72 | EPS Next Est | $-1.18 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $7.61 | 0% | 1.56M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW